Multifunctional hollow CaF2: Yb3+/Er3+/Mn2+-poly(2-Aminoethyl methacrylate) microspheres for Pt(IV) pro-drug delivery and tri-modal imaging

Biomaterials

Volumn 50, Issue 1, 2015, Pages 154-163

  Deng, Xiaoran ^a,b   Dai, Yunlu ^a,b   Liu, Jianhua ^c   Zhou, Ying ^d   Ma, Ping'an ^a   Cheng, Ziyong ^a   Chen, Yinyin ^a,b   Deng, Kerong ^a,b   Li, Xuejiao ^a   Hou, Zhiyao ^a   Li, Chunxia ^a   Lin, Jun ^a  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^d JILIN UNIVERSITY   (China)

Author keywords

CaF2:Yb3+ Er3+ Mn2+; Drug delivery; Hollow microspheres; MRI UCL CT imaging; Poly(2 Aminoethyl methacrylate)

Indexed keywords

CELL CULTURE; DISEASES; DRUG DELIVERY; INFRARED DEVICES; LASER EXCITATION; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; MANGANESE; MEDICAL IMAGING; MICROSPHERES; MOBILE SECURITY; NANOCOMPOSITES; NANOSPHERES; PLATINUM; YTTERBIUM;

CELLULAR ENVIRONMENT; HOLLOW MICROSPHERE; HYBRID MICROSPHERES; HYDROTHERMAL METHODS; IN-VIVO EXPERIMENTS; NEAR-INFRARED LASERS; PHOTO-INITIATED POLYMERIZATIONS; POLY(2-AMINOETHYL METHACRYLATE);

COMPUTERIZED TOMOGRAPHY;

AMINE; ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; ERBIUM; MANGANESE; METHACRYLIC ACID DERIVATIVE; MICROSPHERE; NANOCOMPOSITE; NANOSPHERE; POLY(2 AMINOETHYL METHACRYLATE) MICROSPHERE; POLYMER; PRODRUG; UNCLASSIFIED DRUG; YTTERBIUM; 2-AMINOETHYLMETHACRYLATE; CALCIUM FLUORIDE; PLATINUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOTOXICITY; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; EXCITATION; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; HYBRID; LASER; LUMINESCENCE; MOUSE; MTT ASSAY; NANOFABRICATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; POLYMERIZATION; PRIORITY JOURNAL; TRIMODAL IMAGING; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; MULTIMODAL IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; TEMPERATURE; TUMOR CELL LINE; ULTRASTRUCTURE;

MUS;

ANIMALS; CALCIUM FLUORIDE; CELL LINE, TUMOR; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; ERBIUM; HELA CELLS; HUMANS; LUMINESCENCE; MAGNETIC RESONANCE IMAGING; MANGANESE; METHACRYLATES; MICE; MICROSCOPY, FLUORESCENCE; MICROSPHERES; MULTIMODAL IMAGING; NANOSPHERES; PLATINUM; PRODRUGS; TEMPERATURE; TOMOGRAPHY, X-RAY COMPUTED; YTTERBIUM;

EID: 84932627440     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.01.040     Document Type: Article

References (84)

1. Zhu Y., Shi J., Shen W., Dong X., Feng J., Ruan M., et al. Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell structure. Angew Chem Int Ed 2005, 44:5083-5087.
2. Lou X.W., Archer L.A., Yang Z. Hollow micro-/nanostructures: synthesis and applications. Adv Mater 2008, 20:3987-4019.
3. Lu P.-L., Chen Y.-C., Ou T.-W., Chen H.-H., Tsai H.-C., Wen C.-J., et al. Multifunctional hollow nanoparticles based on graft-diblock copolymers for doxorubicin delivery. Biomaterials 2011, 32:2213-2221.
4. Städler B., Price A.D., Zelikin A.N. Acritical look at multilayered polymer capsules in biomedicine: drug carriers, artificial organelles, and cell mimics. Adv Funct Mater 2011, 21:14-28.
5. Li Y., Shi J. Hollow-structured mesoporous materials: chemical synthesis, functionalization and applications. Adv Mater 2014, 26:3176-3205.
6. Zhao Y., Lin L.-N., Lu Y., Chen S.-F., Dong L., Yu S.-H. Templating synthesis of preloaded doxorubicin in hollow mesoporous silica nanospheres for biomedical applications. Adv Mater 2010, 22:5255-5259.
7. Wang C., Cheng L., Liu Z. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy. Biomaterials 2011, 32:1110-1120.
8. Barreto J.A., O'Malley W., Kubeil M., Graham B., Stephan H., Spiccia L. Nanomaterials: applications in cancer imaging and therapy. Adv Mater 2011, 23:H18-H40.
9. Botella P., Ortega I., Quesada M., Madrigal R.F., Muniesa C., Fimia A., et al. Multifunctional hybrid materials for combined photo and chemotherapy of cancer. Dalton Trans 2012, 41:9286-9296.
10. Luo Z., Ding X., Hu Y., Wu S., Xiang Y., Zeng Y., et al. Engineering a hollow nanocontainer platform with multifunctional molecular machines for tumor-targeted therapy invitro and invivo. ACS Nano 2013, 7:10271-10284.
11. Xue X., Wang F., Liu X. Emerging functional nanomaterials for therapeutics. JMater Chem 2011, 21:13107-13127.
12. Wang F., Liu X. Recent advances in the chemistry of lanthanide-doped upconversion nanocrystals. Chem Soc Rev 2009, 38:976-989.
13. 3+ nanoparticles. Appl Phys Lett 2009, 95.
14. Brites C.D.S., Lima P.P., Silva N.J.O., Millan A., Amaral V.S., Palacio F., et al. Lanthanide-based luminescent molecular thermometers. New J Chem 2011, 35:1177-1183.
15. + doping and their application for bioimaging. Chem A Eur J 2012, 18:9239-9245.
16. 3+ clusters. Light Sci Appl 2014, 3:e193.
17. 3+ nanocrystals. JAm Chem Soc 2009, 131:14200-14201.
18. 3+ nanoparticles: multifunctional nanoprobes for highly penetrating fluorescence bio-imaging. ACS Nano 2011, 5:8665-8671.
19. 2: towards biocompatible materials for biomedical imaging. Biomater Sci 2014, 2:1158-1171.
20. 2 upconversion nanoparticles for simultaneous bioimaging and therapy. Dalton Trans 2014, 43:3861-3870.
21. 3+ hollow spheres as efficient luminescent materials and smart drug carriers. Chem A Eur J 2010, 16:5672-5680.
22. 3+-poly(acrylic acid) hybrid microspheres. Biomaterials 2012, 33:2583-2592.
23. 1 MRI contrast enhancement. Chem Mater 2011, 23:3714-3722.
24. 3+ nanophosphors for upconversion luminescence, mr, and pet imaging of tumor angiogenesis. JNucl Med 2013, 54:96-103.
25. 4 nanoparticles with selected size for optical and MRI imaging. Eur J Inorg Chem 2014, 2014:6075-6084.
26. 5:Yb/Er nanoprobes for multi-modal upconversion fluorescent, invivo X-ray computed tomography and biomagnetic imaging. Biomaterials 2012, 33:9232-9238.
27. 5-based upconversion nanoparticles as drug carriers and multimodal imaging probes. Biomaterials 2014, 35:2011-2023.
28. 4 nanocrystals with improved upconversion fluorescence and MR relaxivity. Nanotechnology 2010, 21:125602.
29. 3+ nanoparticles by active-shell modification. JMater Chem 2011, 21:5923-5927.
30. Zhao Z., Han Y., Lin C., Hu D., Wang F., Chen X., et al. Multifunctional core-shell upconverting nanoparticles for imaging and photodynamic therapy of liver cancer cells. Chem Asian J 2012, 7:830-837.
31. 4:Eu structures for cancer therapy. Chem Commun 2014, 50:4371-4374.
32. 4 core-shell up-conversion nanoparticles for targeted drug delivery and multimodal imaging. Biomaterials 2014, 35:7666-7678.
33. Tian G., Yin W., Jin J., Zhang X., Xing G., Li S., et al. Engineered design of theranostic upconversion nanoparticles for tri-modal upconversion luminescence/magnetic resonance/X-ray computed tomography imaging and targeted delivery of combined anticancer drugs. JMater Chem B 2014, 2:1379-1389.
34. 2-weighted brain tumor diagnosis and MR/UCL/CT multimodal imaging. Adv Funct Mater 2014, 24:6613-6620.
35. 4:Gd/Yb/Er nanorods for blood vessel visualization. Biomaterials 2014, 35:2934-2941.
36. 2-weighted magnetic resonance imaging. Nanoscale 2014, 6:2855-2860.
37. 5:Gd/Yb/Er nanoprobes for dual-modal invivo upconversion luminescence and X-ray bioimaging. Dalton Trans 2014, 43:13343-13348.
38. Sieber M.A., Steger-Hartmann T., Lengsfeld P., Pietsch H. Gadolinium-based contrast agents and NSF: evidence from animal experience. JMagnetic Reson Imaging 2009, 30:1268-1276.
39. 1 magnetic resonance imaging. Chem Commun 2012, 48:10322-10324.
40. 5:Mn/Yb/Er nanoprobes for dual-modal synergistic invivo upconversion luminescence and X-ray bioimaging. JMater Chem B 2014, 2:6527-6533.
41. 4:Yb/Er upconversion nanoparticles for invivo imaging and drug delivery. Adv Mater 2012, 24:1226-1231.
42. Wang C., Cheng L., Liu Y., Wang X., Ma X., Deng Z., et al. Imaging-guided pH-sensitive photodynamic therapy using charge reversible upconversion nanoparticles under near-infrared light. Adv Funct Mater 2013, 23:3077-3086.
43. 2+ doping. Adv Funct Mater 2014, 24:4051-4059.
44. Gu J., Su S., Li Y., He Q., Zhong J., Shi J. Surface modification-complexation strategy for cisplatin loading in mesoporous nanoparticles. JPhys Chem Lett 2010, 1:3446-3450.
45. Della Rocca J., Huxford R.C., Comstock-Duggan E., Lin W. Polysilsesquioxane nanoparticles for targeted platin-based cancer chemotherapy by triggered release. Angew Chem Int Ed 2011, 50:10330-10334.
46. Sastry J., Kellie S.J. Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine. Pediatr Hematol Oncol 2005, 22:441-445.
47. Rieter W.J., Pott K.M., Taylor K.M.L., Lin W. Nanoscale coordination polymers for platinum-based anticancer drug delivery. JAm Chem Soc 2008, 130:11584-11585.
48. Wang X., Guo Z. Targeting and delivery of platinum-based anticancer drugs. Chem Soc Rev 2013, 42:202-224.
49. Dhar S., Daniel W.L., Giljohann D.A., Mirkin C.A., Lippard S.J. Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads. JAm Chem Soc 2009, 131:14652-14653.
50. Min Y., Mao C., Xu D., Wang J., Liu Y. Gold nanorods for platinum based prodrug delivery. Chem Commun 2010, 46:8424-8426.
51. Graf N., Bielenberg D.R., Kolishetti N., Muus C., Banyard J., Farokhzad O.C., et al. αVβ3 integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) Prodrug. ACS Nano 2012, 6:4530-4539.
52. 3+ nanoparticles for targeted drug delivery and up-conversion cell imaging. Adv Healthc Mater 2013, 2:562-567.
53. Dai Y., Xiao H., Liu J., Yuan Q., Pa Ma, Yang D., et al. Invivo multimodality imaging and cancer therapy by near-infrared light-triggered trans-platinum pro-drug-conjugated upconverison nanoparticles. JAm Chem Soc 2013, 135:18920-18929.
54. 2+-NaY as oral gastrointestinal tract contrast agents in magnetic resonance imaging. Acta Chim Sin 2007, 65:2029-2033.
55. 3 nanocrystals. Angew Chem Int Ed 2011, 50:10369-10372.
56. Yu J., Hao R., Sheng F., Xu L., Li G., Hou Y. Hollow manganese phosphate nanoparticles as smart multifunctional probes for cancer cell targeted magnetic resonance imaging and drug delivery. Nano Res 2012, 5:679-694.
57. 1-weighted MRI. Biomaterials 2013, 34:8941-8948.
58. 2-weighted dual mode magnetic resonance imaging. ACS Appl Mater Interfaces 2013, 5:9942-9948.
59. 2 core-shell nanoprobes for targeted magnetic resonance imaging. Nanoscale 2013, 5:10447-10454.
60. 2 nanostructures. JMater Chem C 2014, 2:1736-1741.
61. 2+. Vacuum 2014, 107:311-315.
62. 2+ complexes as potential mri contrast agents. Inorg Chem 2014, 53:5136-5149.
63. Wei W., Zhang Y., Chen R., Goggi J., Ren N., Huang L., et al. Cross relaxation induced pure red upconversion in activator- and sensitizer-rich lanthanide nanoparticles. Chem Mater 2014, 26:5183-5186.
64. Guo L., Cui X., Li Y., He Q., Zhang L., Bu W., et al. Hollow mesoporous carbon spheres with magnetic cores and their performance as separable bilirubin adsorbents. Chem Asian J 2009, 4:1480-1485.
65. Yang P., Gai S., Lin J. Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev 2012, 41:3679-3698.
66. 2 (M=Ca,Sr,Ba) nanocrystals and their optical properties. Nanotechnology 2008, 19:075603.
67. Thompson K.L., Read E.S., Armes S.P. Chemical degradation of poly(2-aminoethyl methacrylate). Polym Degrad Stab 2008, 93:1460-1466.
68. Chen Z., Chen H., Hu H., Yu M., Li F., Zhang Q., et al. Versatile synthesis strategy for carboxylic acid-functionalized upconverting nanophosphors as biological labels. JAm Chem Soc 2008, 130:3023-3029.
69. Wang H.-Q., Nann T. Monodisperse upconverting nanocrystals by microwave-assisted synthesis. ACS Nano 2009, 3:3804-3808.
70. Cheng L., Yang K., Shao M., Lee S.-T., Liu Z. Multicolor invivo imaging of upconversion nanoparticles with emissions tuned by luminescence resonance energy transfer. JPhys Chem C 2011, 115:2686-2692.
71. Parker D.L., Sposito G., Tebo B.M. Manganese(III) binding to a pyoverdine siderophore produced by a manganese(II)-oxidizing bacterium. Geochimica Cosmochimica Acta 2004, 68:4809-4820.
72. 2 nanocrystals. JCryst Growth 2003, 257:84-88.
73. Zeng J.H., Xie T., Li Z.H., Li Y. Monodispersed nanocrystalline fluoroperovskite up-conversion phosphors. Cryst Growth & Des 2007, 7:2774-2777.
74. 2 nanocrystals with bright red up-converted fluorescence. Scr Mater 2009, 60:190-193.
75. Na H.B., Lee J.H., An K., Park Y.I., Park M., Lee I.S., et al. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem 2007, 119:5493-5497.
76. 1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem Int Ed 2007, 46:5397-5401.
77. Liu Y., Ai K., Liu J., Yuan Q., He Y., Lu L. AHigh-performance ytterbium-based nanoparticulate contrast agent for invivo X-ray computed tomography imaging. Angew Chem Int Ed 2012, 51:1437-1442.
78. Li F., Li C., Liu J., Liu X., Zhao L., Bai T., et al. Aqueous phase synthesis of upconversion nanocrystals through layer-by-layer epitaxial growth for invivo X-ray computed tomography. Nanoscale 2013, 5:6950-6959.
79. Liu Y., Ai K., Lu L. Nanoparticulate X-ray computed tomography contrast agents: from design validation to invivo applications. Accounts Chem Res 2012, 45:1817-1827.
80. 3+ nanoprobe for CT and NIR-to-NIR fluorescent bimodal imaging. Biomaterials 2012, 33:5384-5393.
81. Xiao H., Qi R., Liu S., Hu X., Duan T., Zheng Y., et al. Biodegradable polymer - cisplatin (IV) conjugate as a pro-drug of cisplatin(II). Biomaterials 2011, 32:7732-7739.
82. Hall M.D., Amjadi S., Zhang M., Beale P.J., Hambley T.W. The mechanism of action of platinum (IV) complexes in ovarian cancer cell lines. JInorg Biochem 2004, 98:1614-1624.
83. Moore M.N. Do nanoparticles present ecotoxicological risks for the health of the aquatic environment. Environ Int 2006, 32:967-976.
84. Yang J., Liu W., Sui M., Tang J., Shen Y. Platinum (IV)-coordinate polymers as intracellular reduction-responsive backbone-type conjugates for cancer drug delivery. Biomaterials 2011, 32:9136-9143.